Show simple item record

dc.contributor.authorKenz, Sami
dc.contributor.authorHaas, C S
dc.contributor.authorWerth, S C
dc.contributor.authorBohnet, S
dc.contributor.authorBrabant, Georg E
dc.date.accessioned2012-04-20T10:06:25Z
dc.date.available2012-04-20T10:06:25Z
dc.date.issued2011-12
dc.identifier.citationHigh sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH). 2011, 22 (12):2696 Ann Oncolen_GB
dc.identifier.issn1569-8041
dc.identifier.pmid22021821
dc.identifier.doi10.1093/annonc/mdr431
dc.identifier.urihttp://hdl.handle.net/10541/219591
dc.language.isoenen
dc.rightsArchived with thanks to Annals of oncology : official journal of the European Society for Medical Oncology / ESMOen_GB
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshBenzazepines
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInappropriate ADH Syndrome
dc.subject.meshLung Neoplasms
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNatriuretic Agents
dc.subject.meshParaneoplastic Endocrine Syndromes
dc.subject.meshSmall Cell Lung Carcinoma
dc.subject.meshTreatment Outcome
dc.titleHigh sensitivity to tolvaptan in paraneoplastic syndrome of inappropriate ADH secretion (SIADH).en
dc.typeArticleen
dc.contributor.departmentThe Christie Hospital NHS Foundation Trust, Manchesteren_GB
dc.identifier.journalAnnals of Oncologyen_GB


This item appears in the following Collection(s)

Show simple item record